DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Lip GY. et al.
Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy.
Thromb Haemost 2015;
114: 826-834.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.